$5.65
0.62[12.33%]
At close: Mar 12
$5.65
0[0.00%]
PreMarket: 7:15PM EDT
Champions Oncology
(NASDAQ:CSBR)Champions Oncology Stock (NASDAQ:CSBR), Analyst Ratings, Price Targets, Predictions
Champions Oncology Inc has a consensus price target of $3.75, established from looking at the 2 latest analyst ratings. The last 2 analyst ratings were released from Craig-Hallum and Roth MKM on March 13, 2024 and September 22, 2023. With an average price target of $3.75 between Craig-Hallum and Roth MKM, there's an implied -33.63% downside for Champions Oncology Inc from these 2 analyst ratings.
Analyst Firms Making Recommendations1
Craig-Hallum
Roth MKM
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Champions Oncology
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/13/2024 | CSBR | Buy Now | Champions Oncology | $5.65 | — | Craig-Hallum | Matt Hewitt | — | Downgrade | Buy → Hold | Get Alert |
| 09/22/2023 | CSBR | Buy Now | Champions Oncology | $5.65 | 32.74% | Roth MKM | Scott Henry | $9 → $7.5 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Champions Oncology (CSBR)?
The latest price target for Champions Oncology (NASDAQ: CSBR) was reported by Craig-Hallum on March 13, 2024. The analyst firm set a price target for $0.00 expecting CSBR to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Champions Oncology (CSBR)?
The latest analyst rating for Champions Oncology (NASDAQ: CSBR) was provided by Craig-Hallum, and Champions Oncology downgraded their hold rating.
When was the last upgrade for Champions Oncology (CSBR)?
There is no last upgrade for Champions Oncology.
When was the last downgrade for Champions Oncology (CSBR)?
The last downgrade for Champions Oncology Inc happened on March 13, 2024 when Craig-Hallum changed their price target from N/A to N/A for Champions Oncology Inc.
When is the next analyst rating going to be posted or updated for Champions Oncology (CSBR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Champions Oncology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Champions Oncology was filed on March 13, 2024 so you should expect the next rating to be made available sometime around March 13, 2025.
Is the Analyst Rating Champions Oncology (CSBR) correct?
While ratings are subjective and will change, the latest Champions Oncology (CSBR) rating was a downgraded with a price target of $0.00 to $0.00. The current price Champions Oncology (CSBR) is trading at is $5.65, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.